Your browser doesn't support javascript.
loading
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines.
Bowen, John E; Park, Young-Jun; Stewart, Cameron; Brown, Jack T; Sharkey, William K; Walls, Alexandra C; Joshi, Anshu; Sprouse, Kaitlin R; McCallum, Matthew; Tortorici, M Alejandra; Franko, Nicholas M; Logue, Jennifer K; Mazzitelli, Ignacio G; Nguyen, Annalee W; Silva, Rui P; Huang, Yimin; Low, Jun Siong; Jerak, Josipa; Tiles, Sasha W; Ahmed, Kumail; Shariq, Asefa; Dan, Jennifer M; Zhang, Zeli; Weiskopf, Daniela; Sette, Alessandro; Snell, Gyorgy; Posavad, Christine M; Iqbal, Najeeha Talat; Geffner, Jorge; Bandera, Alessandra; Gori, Andrea; Sallusto, Federica; Maynard, Jennifer A; Crotty, Shane; Van Voorhis, Wesley C; Simmerling, Carlos; Grifantini, Renata; Chu, Helen Y; Corti, Davide; Veesler, David.
Afiliação
  • Bowen JE; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Park YJ; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Stewart C; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.
  • Brown JT; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Sharkey WK; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Walls AC; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Joshi A; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Sprouse KR; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.
  • McCallum M; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Franko NM; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Logue JK; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  • Mazzitelli IG; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA.
  • Nguyen AW; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA.
  • Silva RP; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Facultad de Medicina, Buenos Aires C1121ABG, Argentina.
  • Huang Y; McKetta Department of Chemical Engineering, University of Texas at Austin, Austin, TX 78712, USA.
  • Low JS; McKetta Department of Chemical Engineering, University of Texas at Austin, Austin, TX 78712, USA.
  • Jerak J; McKetta Department of Chemical Engineering, University of Texas at Austin, Austin, TX 78712, USA.
  • Tiles SW; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.
  • Ahmed K; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.
  • Shariq A; Center for Emerging and Re-emerging Infectious Diseases, Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.
  • Dan JM; Departments of Paediatrics and Child Health and Biological and Biomedical Sciences, Aga Khan University, Karachi 74800, Pakistan.
  • Zhang Z; Departments of Paediatrics and Child Health and Biological and Biomedical Sciences, Aga Khan University, Karachi 74800, Pakistan.
  • Weiskopf D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
  • Sette A; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, CA UC92037, USA.
  • Snell G; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
  • Posavad CM; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, CA UC92037, USA.
  • Iqbal NT; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
  • Geffner J; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, CA UC92037, USA.
  • Bandera A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
  • Gori A; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, CA UC92037, USA.
  • Sallusto F; Vir Biotechnology, San Francisco, CA 94158, USA.
  • Maynard JA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
  • Crotty S; Departments of Paediatrics and Child Health and Biological and Biomedical Sciences, Aga Khan University, Karachi 74800, Pakistan.
  • Van Voorhis WC; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Facultad de Medicina, Buenos Aires C1121ABG, Argentina.
  • Simmerling C; Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Grifantini R; Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Chu HY; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.
  • Corti D; McKetta Department of Chemical Engineering, University of Texas at Austin, Austin, TX 78712, USA.
  • Veesler D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Sci Immunol ; 7(78): eadf1421, 2022 12 23.
Article em En | MEDLINE | ID: mdl-36356052
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Sci Immunol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Sci Immunol Ano de publicação: 2022 Tipo de documento: Article